Integra Lifesciences Holdings Corp
F:IL3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Integra Lifesciences Holdings Corp
F:IL3
|
US |
|
H
|
Haseko Corp
F:HS6
|
JP |
|
D
|
DPC Dash Ltd
OTC:DPCDF
|
CN |
|
Spinnova Oyj
F:9HP
|
FI |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
XHAM:AIL
|
FR |
|
Everbright Securities Co Ltd
F:0EC
|
CN |
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
Mentice AB
F:MN2
|
SE |
|
Creative Realities Inc
NASDAQ:CREX
|
US |
|
A
|
Ad Pepper Media International NV
F:APM
|
DE |
|
PPC Ltd
F:OZV2
|
ZA |
|
W
|
Wolverine World Wide Inc
F:WW4
|
US |
Wall St Price Targets
IL3 Price Targets Summary
Integra Lifesciences Holdings Corp
According to Wall Street analysts, the average 1-year price target for IL3 is 16.87 EUR with a low forecast of 10.97 EUR and a high forecast of 28 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IL3's stock price target?
Price Target
16.87
EUR
According to Wall Street analysts, the average 1-year price target for IL3 is 16.87 EUR with a low forecast of 10.97 EUR and a high forecast of 28 EUR.
What is the Revenue forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Integra Lifesciences Holdings Corp?
Projected CAGR
24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 3%. The projected CAGR for the next 3 years is 24%.
